New eye injection trial seeks to control Diabetes-Related vision loss
Disease control
Not yet recruiting
This early-stage study aims to check the safety of a new eye injection called PRO-169 for people with diabetic macular edema, a condition that causes vision loss. The main goal is to see if the body's immune system reacts to the drug by measuring antibodies in the blood. The stud…
Phase: PHASE1 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC